Activity Overview
This educational activity is an archive of the live conference held on July 24 and 25, 2026.
Target Audience
This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Formulate approaches to integrate monotherapy and combination immunotherapeutic approaches in the management of patients with lung cancer
- Analyze recent clinical trial evidence as well as ongoing trials for the management of patients with lung cancer
Hossein Borghaei, DO, MS
Professor, Department of Hematology/Oncology
Chief, Division of Thoracic Medical Oncology
Co-Director, Immune Monitoring Facility
Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Fox Chase Cancer Center
Philadelphia, PA
Turja Chakrabarti, MD, MS
Y3 Clinical and Research Fellow
Department of Hematology and Medical Oncology
City of Hope Comprehensive Cancer Center
Duarte, CA
Matthew Gubens, MD, MS, FASCO
Professor of Medicine
Medical Director, Thoracic Medical Oncology
University of California, San Francisco
San Francisco, CA
Christine M. Lovly, MD, PhD, FASCO
Division Chief, Thoracic Medical Oncology
Professor, Department of Medical Oncology & Therapeutics Research
Dr Norman and Melinda Payson Professor in Medical Oncology
City of Hope Comprehensive Cancer Center
Duarte, CA
Jorge J. Nieva, MD
Professor of Clinical Medicine
Section Head, Lung and Head/Neck Tumors
USC Norris Comprehensive Cancer Center
Keck School of Medicine
University of Southern California
Los Angeles, CA
Solange Peters, MD, PhD
Full Professor
Chair of Medical Oncology and Oncology Program
University Hospital of Lausanne
Lausanne, Switzerland
Jonathan W. Riess, MD, MS
Professor of Medicine
Director, Thoracic Oncology
Medical Director – Phase I Clinical Trials, Office of Clinical Research
UC Davis Comprehensive Cancer Center
Sacramento, CA
Himani Singh, MD
Medical Oncologist
North County Oncology
Oceanside, CA
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here